Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine in acute exacerbation of schizophrenia
NCT00694707Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Jun 2008
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 2 trial of cariprazine in schizophrenia, sponsored by Forest Laboratories. Started Jun 2008; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00694707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694707.